Eli Lilly stock slides for second straight day

8 articles · Updated · MarketWatch · May 7

Shares fell 1.22% to $974.96 on Thursday, while the S&P 500 dropped 0.38% and the Dow Jones Industrial Average lost 0.63%.
The stock closed 14.02% below its 52-week high of $1,133.95 reached on 8 January and lagged peers including Johnson & Johnson, Pfizer and AbbVie.
Trading volume reached 3.3 million shares, above its 50-day average of 3.1 million, during a broadly weaker session for US equities.

Eli Lilly’s profits are soaring, so why is its stock suddenly stumbling?

Is the new oral weight-loss pill a game-changer or a risky gamble for Eli Lilly?